Last reviewed · How we verify

Oral capsule faecal microbiota transplantation

Tan Tock Seng Hospital · Phase 3 active Biologic

Oral capsule faecal microbiota transplantation is a Biologic drug developed by Tan Tock Seng Hospital. It is currently in Phase 3 development for Treatment-resistant Clostridioides difficile infection, Ulcerative colitis, Irritable bowel syndrome. Also known as: capsule FMT, FMT.

Oral capsule faecal microbiota transplantation involves the transfer of live microbes from a donor into the patient's gastrointestinal tract to restore a healthy balance of gut bacteria.

Oral capsule faecal microbiota transplantation involves the transfer of live microbes from a donor into the patient's gastrointestinal tract to restore a healthy balance of gut bacteria. Used for Treatment-resistant Clostridioides difficile infection, Ulcerative colitis, Irritable bowel syndrome.

At a glance

Generic nameOral capsule faecal microbiota transplantation
Also known ascapsule FMT, FMT
SponsorTan Tock Seng Hospital
ModalityBiologic
Therapeutic areaGastroenterology
PhasePhase 3

Mechanism of action

This process aims to treat various conditions by introducing beneficial microbes that can help to crowd out pathogenic bacteria, promoting a balanced gut microbiome. The exact mechanisms of action are not fully understood, but it is thought to involve the modulation of the immune system and the production of certain metabolites.

Approved indications

Common side effects

Key clinical trials

Primary sources

Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.

SourceUsed for
ClinicalTrials.govTrial enrolment, design, endpoints, results

Competitive intelligence

For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:

Frequently asked questions about Oral capsule faecal microbiota transplantation

What is Oral capsule faecal microbiota transplantation?

Oral capsule faecal microbiota transplantation is a Biologic drug developed by Tan Tock Seng Hospital, indicated for Treatment-resistant Clostridioides difficile infection, Ulcerative colitis, Irritable bowel syndrome.

How does Oral capsule faecal microbiota transplantation work?

Oral capsule faecal microbiota transplantation involves the transfer of live microbes from a donor into the patient's gastrointestinal tract to restore a healthy balance of gut bacteria.

What is Oral capsule faecal microbiota transplantation used for?

Oral capsule faecal microbiota transplantation is indicated for Treatment-resistant Clostridioides difficile infection, Ulcerative colitis, Irritable bowel syndrome.

Who makes Oral capsule faecal microbiota transplantation?

Oral capsule faecal microbiota transplantation is developed by Tan Tock Seng Hospital (see full Tan Tock Seng Hospital pipeline at /company/tan-tock-seng-hospital).

Is Oral capsule faecal microbiota transplantation also known as anything else?

Oral capsule faecal microbiota transplantation is also known as capsule FMT, FMT.

What development phase is Oral capsule faecal microbiota transplantation in?

Oral capsule faecal microbiota transplantation is in Phase 3.

What are the side effects of Oral capsule faecal microbiota transplantation?

Common side effects of Oral capsule faecal microbiota transplantation include Abdominal pain, Diarrhea, Nausea.

Related